Is Cranial Magnetic Resonance Imaging (MRI) Necessary for Staging of Asymptomatic HER2-Positive Breast Cancer Patients?

dc.contributor.authorKaplan, M. A.
dc.contributor.authorInai, A.
dc.contributor.authorKucukoner, M.
dc.contributor.authorUrakci, Z.
dc.contributor.authorIsikdogan, A.
dc.date.accessioned2024-04-24T17:12:18Z
dc.date.available2024-04-24T17:12:18Z
dc.date.issued2011
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1158/0008-5472.SABCS11-P4-17-08
dc.identifier.issn0008-5472
dc.identifier.issn1538-7445
dc.identifier.urihttps://doi.org/10.1158/0008-5472.SABCS11-P4-17-08
dc.identifier.urihttps://hdl.handle.net/11468/17924
dc.identifier.volume71en_US
dc.identifier.wosWOS:000209699801418
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherAmer Assoc Cancer Researchen_US
dc.relation.ispartofCancer Research
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleIs Cranial Magnetic Resonance Imaging (MRI) Necessary for Staging of Asymptomatic HER2-Positive Breast Cancer Patients?en_US
dc.titleIs Cranial Magnetic Resonance Imaging (MRI) Necessary for Staging of Asymptomatic HER2-Positive Breast Cancer Patients?
dc.typeConference Objecten_US

Dosyalar